Clinical Trial Update: A Drug Safety and Dose-exploratory Clinical Study of Azvudine Tablets in Patients Who Have Not Received Anti-HIV Treatment [Phase 2]

View source ↗

Summary

Phase 2 safety and dose-exploration trial of Azvudine tablets in treatment-naïve patients with AIDS has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Azvudine (azvudine)

Snippet

Sponsor: Henan Genuine Biotech Co., Ltd. | Conditions: AIDS | Phase 2 | Status: COMPLETED